HRAUX
Price
$91.72
Change
-$0.44 (-0.48%)
Updated
Nov 13 closing price
PMAQX
Price
$48.46
Change
+$0.16 (+0.33%)
Updated
Nov 13 closing price
Ad is loading...

HRAUX vs PMAQX

Header iconHRAUX vs PMAQX Comparison
Open Charts HRAUX vs PMAQXBanner chart's image
Carillon Eagle Mid Cap Growth R6
Price$91.72
Change-$0.44 (-0.48%)
VolumeN/A
CapitalizationN/A
Principal MidCap R6
Price$48.46
Change+$0.16 (+0.33%)
VolumeN/A
CapitalizationN/A
HRAUX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HRAUX vs. PMAQX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRAUX is a Buy and PMAQX is a Buy.

FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.8B vs. HRAUX (6.72B). PMAQX pays higher dividends than HRAUX: PMAQX (0.10) vs HRAUX (0.00). HRAUX was incepted earlier than PMAQX: HRAUX (13 years) vs PMAQX (8 years). PMAQX is a more actively managed with annual turnover of: 10.10 vs. HRAUX (3.00). HRAUX (0) and PMAQX (0) have matching initial minimum investment requirements. PMAQX annual gain was more profitable for investors over the last year : 32.12 vs. HRAUX (16.66). PMAQX return over 5 years is better than : 55.10 vs. HRAUX (31.95).
HRAUXPMAQXHRAUX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years8 years-
Gain YTD17.96826.39568%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets6.72B29.8B23%
Annual Yield % from dividends0.000.10-
Returns for 1 year16.6632.1252%
Returns for 3 years-19.716.88-286%
Returns for 5 years31.9555.1058%
Returns for 10 years92.93N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LIXT1.65-0.03
-1.79%
Lixte Biotechnology Holdings
ATRO16.49-0.38
-2.25%
Astronics Corp
LFST7.22-0.18
-2.43%
LifeStance Health Group
CVNA239.98-6.77
-2.74%
Carvana Co
IPSC1.33-0.08
-5.67%
Century Therapeutics